Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Efficacy of Oxymetazoline on Clinical Symptoms and Cilia Function Following Radiofrequency Turbinate Reduction
TCTR20230321012Phase 3Unknown
- Sponsor
- N/A
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of oxymetazoline in nasal congestion, inferior turbinate hypertrophy, chronic rhinitis, sponsored by N/A. Status: unknown.
02
Drugs
oxymetazoline
03
Conditions
nasal congestioninferior turbinate hypertrophychronic rhinitis
Beyond the preview
Go deeper on TCTR20230321012.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20230321012.